Protalix BioTherapeutics (PLX) Tops Q1 EPS by 3c, Revenues Beat

Go back to Protalix BioTherapeutics (PLX) Tops Q1 EPS by 3c, Revenues Beat
PROTALIX BIOTHERAPEUTICS, INC. COMMON STOCK (NYSE: PLX) Delayed: 2.16 -0.06 (2.7%)
Previous Close $2.22    52 Week High $1.11 
Open $2.21    52 Week Low $0.41 
Day High $2.27    P/E N/A 
Day Low $2.14    EPS $-0.29 
Volume 723,459